Developer docs
API playgroundTry for free, no card

Search company profiles

B Cell Design

Full company profile

uuid000gqzl

Namestring
B Cell Design
Legal namestring
Bcell Design
Company typeenum
Private
Founded yearint
2007
Descriptiontext

B Cell Design is a privately-held French biotechnology company, founded in 2007 and headquartered in Illkirch-Graffenstaden, France. The company specializes in developing, producing, and distributing human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry, serving as a recombinant alternative to disease-state plasma for use as positive controls, calibrators, and quality control materials in immunoassays. Its core technology combines hybridoma methods with proprietary transgenic mouse platforms — InEps® (for IgM), Gamma®/GammaPrim® (for IgG), and Hamiga® (for IgA) — where the murine Ig heavy chain constant region is replaced by human Ig sequences, enabling production of fully human Fc chimeric antibodies with 98% purity and coefficient of variation below 5%. The portfolio spans over 70 catalog products across infectious diseases (e.g., Borrelia, CMV, Rubella, SARS-CoV-2), autoimmunity (e.g., SLA, Jo-1, rheumatoid factor), and allergies/food intolerances (e.g., Derf2, gliadin, tissue transglutaminase), complemented by custom antibody development services and analytical services (epitope mapping, paratope mapping, kinetics measurement).

The company operates a sales-led go-to-market motion targeting IVD manufacturers and diagnostic laboratories, distributing directly through its website and via a global network of distributors (Diarect/BBI Solutions, 2BScientific, Biokit, Operon, D-tek, Abcely, Aesku, Yarewell, among others). Pricing is quote-based and not publicly disclosed. Named enterprise customers include Werfen, BioVendor R&D, Virion-serion, and the ECAT Foundation, with multiple multi-year supply relationships. The company holds ISO 9001 certification and is compliant with IVDR and FDA 21 CFR Part 820 standards, positioning it to serve regulated diagnostic markets. Founded by Armelle Cuvillier (CSO) and Gaël Champier (CEO), with Michel Cogné (Académie des Sciences) as Scientific Advisor, the firm exhibits at industry events including MEDICA 2024 and pursues academic collaborations with Université de Tours and Université Jean Monnet to extend its platform.

Short descriptiontext

B Cell Design is a French biotechnology company that develops and produces patented human Fc monoclonal antibodies for IVD manufacturers as recombinant alternatives to disease-state plasma, serving as positive controls and calibrators in diagnostic immunoassays across infectious disease, autoimmunity, and allergy verticals.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIllkirch-graffenstaden, France
HQ citystring
Illkirch-graffenstaden
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
monoclonal antibody development, human Fc antibodies, in vitro diagnostics, transgenic mouse platforms, hybridoma technology
Industry2 codes
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics
NAICS code1 code
  • In-Vitro Diagnostic Substance Manufacturing325413
SIC code1 code
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
In Vitro Diagnostics Reagents
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Monoclonal Antibody Product Sales
TypeOne Time License
Description

B Cell Design develops, produces and distributes high-quality human Fc monoclonal antibodies for the diagnostic industry. Products are sold directly and through distributors for use as positive controls, calibrators, and quality control materials in IVD kits. Revenue is generated through product sales with pricing based on quote requests.

b-cell-design.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

B Cell Design develops, produces, and distributes human Fc monoclonal antibodies for the in vitro diagnostic (IVD) industry, generated through proprietary transgenic mouse platforms (InEps®, Gamma®/GammaPrim®, Hamiga®). The company offers a catalog of 70+ antibody clones targeting infectious disease, autoimmunity, and allergy biomarkers, alongside custom antibody development and analytical services including epitope mapping, paratope mapping, and kinetics measurement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • CV below 5% compared to ~20% for plasma-based materials
+3 more records
Product overview1 text field

B Cell Design is a biotechnology company that develops, produces, and distributes human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry. The product portfolio consists of over 70 monoclonal antibody products spanning three therapeutic areas: Infectious Diseases (IgM/IgA antibodies targeting pathogens including Borrelia, Chikungunya, CMV, Rubella, Toxoplasma, VZV, Mumps, Brucella, SARS-CoV-2 RBD, Zika, Dengue), Autoimmunity (IgG/IgM antibodies targeting autoimmune disease markers including SLA, PDCE2, LC1, Jo-1, KS, SP100, Rheumatoid Factor, TPO), and Allergies/Food Intolerances (IgE/IgA/IgG antibodies targeting allergens including Derf2, ovalbumin, beta-lactoglobulin, gliadin, tissue transglutaminase, and insulin). All products are produced using hybridoma technology with proprietary transgenic mouse platforms (InEps for IgM, Gamma/GammaPrim for IgG, Hamiga for IgA) and serve as alternatives to disease state plasma, functioning as positive controls and calibrators for IVD kits. The company also offers Custom Monoclonal Antibody Development Services for generating tailored human Fc mAbs and Analytical Services including epitope mapping, paratope mapping, and kinetics measurement.

Product and service1 record
1Custom Monoclonal Antibody Development Services
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership14 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Werfen, an IVD manufacturer, partners with B Cell Design for stable and reliable sources of standard materials. Collaboration described as profitable and satisfactory for developing and manufacturing IVD products.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

BioVendor R&D values cooperation with B Cell Design, utilizing the unique chimeric antibody production capability. Company appreciates excellent communication, high expertise, innovative ideas, and meeting deadlines.

3Diarect / BBI Solutions
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

b-cell-design.com
4Virion-serion
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Over 5-year collaboration with Virion-serion. B Cell Design's patented technology and experience enabled joint development of excellent IgM antibodies for Virion-serion's product portfolio.

b-cell-design.com
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Since 2020, ECAT Foundation uses B Cell Design's human chimeric IgG anti-PF4/H (clone 1C12) for quality control samples in external quality assessment programme for HIT testing.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner listed in B Cell Design's partner ecosystem.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Academic partner listed in B Cell Design's partner ecosystem.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

12Abcely
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

b-cell-design.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

14Yarewell
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/distributor in the B Cell Design partner ecosystem.

b-cell-design.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

B Cell Design

In Vitro Diagnostics Reagentsb-cell-design.com

B Cell Design is a French biotechnology company that develops and produces patented human Fc monoclonal antibodies for IVD manufacturers as recombinant alternatives to disease-state plasma, serving as positive controls and calibrators in diagnostic immunoassays across infectious disease, autoimmunity, and allergy verticals.

What B Cell Design does

B Cell Design is a privately-held French biotechnology company, founded in 2007 and headquartered in Illkirch-Graffenstaden, France. The company specializes in developing, producing, and distributing human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry, serving as a recombinant alternative to disease-state plasma for use as positive controls, calibrators, and quality control materials in immunoassays. Its core technology combines hybridoma methods with proprietary transgenic mouse platforms — InEps® (for IgM), Gamma®/GammaPrim® (for IgG), and Hamiga® (for IgA) — where the murine Ig heavy chain constant region is replaced by human Ig sequences, enabling production of fully human Fc chimeric antibodies with 98% purity and coefficient of variation below 5%. The portfolio spans over 70 catalog products across infectious diseases (e.g., Borrelia, CMV, Rubella, SARS-CoV-2), autoimmunity (e.g., SLA, Jo-1, rheumatoid factor), and allergies/food intolerances (e.g., Derf2, gliadin, tissue transglutaminase), complemented by custom antibody development services and analytical services (epitope mapping, paratope mapping, kinetics measurement).

The company operates a sales-led go-to-market motion targeting IVD manufacturers and diagnostic laboratories, distributing directly through its website and via a global network of distributors (Diarect/BBI Solutions, 2BScientific, Biokit, Operon, D-tek, Abcely, Aesku, Yarewell, among others). Pricing is quote-based and not publicly disclosed. Named enterprise customers include Werfen, BioVendor R&D, Virion-serion, and the ECAT Foundation, with multiple multi-year supply relationships. The company holds ISO 9001 certification and is compliant with IVDR and FDA 21 CFR Part 820 standards, positioning it to serve regulated diagnostic markets. Founded by Armelle Cuvillier (CSO) and Gaël Champier (CEO), with Michel Cogné (Académie des Sciences) as Scientific Advisor, the firm exhibits at industry events including MEDICA 2024 and pursues academic collaborations with Université de Tours and Université Jean Monnet to extend its platform.

B Cell Design firmographics

Firmographics
Name
B Cell Design
Legal name
Bcell Design
Website
https://b-cell-design.com
Company type
Private
Founded year
2007
Operating status
Operating
Headcount range
1–10 employees
Short description
B Cell Design is a French biotechnology company that develops and produces patented human Fc monoclonal antibodies for IVD manufacturers as recombinant alternatives to disease-state plasma, serving as positive controls and calibrators in diagnostic immunoassays across infectious disease, autoimmunity, and allergy verticals.
Ownership category
akta.pro rank

B Cell Design industry classification

Industry
Product category
In Vitro Diagnostics Reagents
NAICS
In-Vitro Diagnostic Substance Manufacturing (325413)
SIC
In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAAAIAB
Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering)
Healthcare & Life Sciences/Biotechnology & Biologics/Biologic Drug Discovery Platforms (screening, antibody engineering, synthetic biology)
SECONDARYHLAAAMAL
Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls)
Healthcare & Life Sciences/Biotechnology & Biologics/Biomarkers and Companion Diagnostics

Keywords

  • Monoclonal antibody development
  • Human Fc antibodies
  • In vitro diagnostics
  • Transgenic mouse platforms
  • Hybridoma technology

Where B Cell Design is headquartered

Location

Headquarters

HQ city
Illkirch-graffenstaden
HQ country
France
HQ region
Europe

Offices1 record

Markets served

B Cell Design business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Monoclonal Antibody Product Sales: B Cell Design develops, produces and distributes high-quality human Fc monoclonal antibodies for the diagnostic industry. Products are sold directly and through distributors for use as positive controls, calibrators, and quality control materials in IVD kits. Revenue is generated through product sales with pricing based on quote requests.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels5 records

B Cell Design product offering

Product offering

Core offering

B Cell Design develops, produces, and distributes human Fc monoclonal antibodies for the in vitro diagnostic (IVD) industry, generated through proprietary transgenic mouse platforms (InEps®, Gamma®/GammaPrim®, Hamiga®). The company offers a catalog of 70+ antibody clones targeting infectious disease, autoimmunity, and allergy biomarkers, alongside custom antibody development and analytical services including epitope mapping, paratope mapping, and kinetics measurement.

Product overview

B Cell Design is a biotechnology company that develops, produces, and distributes human Fc monoclonal antibodies (mAbs) for the in vitro diagnostic (IVD) industry. The product portfolio consists of over 70 monoclonal antibody products spanning three therapeutic areas: Infectious Diseases (IgM/IgA antibodies targeting pathogens including Borrelia, Chikungunya, CMV, Rubella, Toxoplasma, VZV, Mumps, Brucella, SARS-CoV-2 RBD, Zika, Dengue), Autoimmunity (IgG/IgM antibodies targeting autoimmune disease markers including SLA, PDCE2, LC1, Jo-1, KS, SP100, Rheumatoid Factor, TPO), and Allergies/Food Intolerances (IgE/IgA/IgG antibodies targeting allergens including Derf2, ovalbumin, beta-lactoglobulin, gliadin, tissue transglutaminase, and insulin). All products are produced using hybridoma technology with proprietary transgenic mouse platforms (InEps for IgM, Gamma/GammaPrim for IgG, Hamiga for IgA) and serve as alternatives to disease state plasma, functioning as positive controls and calibrators for IVD kits. The company also offers Custom Monoclonal Antibody Development Services for generating tailored human Fc mAbs and Analytical Services including epitope mapping, paratope mapping, and kinetics measurement.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Monoclonal Antibody Development Services

Quantifiable outcome

  • CV below 5% compared to ~20% for plasma-based materials
  • +3 more outcomes

Companies that use B Cell Design

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles2 records

B Cell Design technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

B Cell Design partnerships and signals

Strategic signal

Partnerships

14 partnerships are on record, tiered core and minor.

  • WerfencoreChannel Partner/ Reseller/ DistributorWerfen, an IVD manufacturer, partners with B Cell Design for stable and reliable sources of standard materials. Collaboration described as profitable and satisfactory for developing and manufacturing IVD products.
  • BioVendor R&DcoreChannel Partner/ Reseller/ DistributorBioVendor R&D values cooperation with B Cell Design, utilizing the unique chimeric antibody production capability. Company appreciates excellent communication, high expertise, innovative ideas, and meeting deadlines.
  • Diarect / BBI SolutionsminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • Virion-serioncoreStrategic or Co-development PartnerOver 5-year collaboration with Virion-serion. B Cell Design's patented technology and experience enabled joint development of excellent IgM antibodies for Virion-serion's product portfolio.
  • ECAT FoundationcoreChannel Partner/ Reseller/ DistributorSince 2020, ECAT Foundation uses B Cell Design's human chimeric IgG anti-PF4/H (clone 1C12) for quality control samples in external quality assessment programme for HIT testing.
  • Université de ToursminorStrategic or Co-development PartnerAcademic partner listed in B Cell Design's partner ecosystem.
  • Université Jean MonnetminorStrategic or Co-development PartnerAcademic partner listed in B Cell Design's partner ecosystem.
  • 2BScientificminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • BiokitminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • OperonminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • D-tekminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • AbcelyminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • AeskuminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.
  • YarewellminorChannel Partner/ Reseller/ DistributorListed as a partner/distributor in the B Cell Design partner ecosystem.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

B Cell Design competitors and assessment

Company assessment

Market position

Strengths5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

B Cell Design social profiles

Digital presence

B Cell Design compliance and trust

Trust signal

Compliance3 records

B Cell Design financial estimates

Financial estimate

Revenue estimate

Valuation estimate

B Cell Design leadership team

Management profile

Number of profiles

Profiles5 records

B Cell Design funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

B Cell Design M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about B Cell Design

What does B Cell Design do?

B Cell Design develops, produces, and distributes human Fc monoclonal antibodies for the in vitro diagnostic (IVD) industry, generated through proprietary transgenic mouse platforms (InEps®, Gamma®/GammaPrim®, Hamiga®). The company offers a catalog of 70+ antibody clones targeting infectious disease, autoimmunity, and allergy biomarkers, alongside custom antibody development and analytical services including epitope mapping, paratope mapping, and kinetics measurement.

Is B Cell Design a public or private company?

B Cell Design is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was B Cell Design founded?

B Cell Design was founded in 2007. It employs 1 to 10 people.

Where is B Cell Design based?

B Cell Design is headquartered in Illkirch-graffenstaden, France, in the Europe region.

How does B Cell Design make money?

One revenue line is on record: monoclonal Antibody Product Sales.

Does B Cell Design have an API?

No public API is recorded for B Cell Design.

What industry is B Cell Design in?

B Cell Design's product category is In Vitro Diagnostics Reagents. Its primary akta.pro industry code is HLAAAIAB, Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2835.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals